Results 31 to 40 of about 947,797 (169)

Efficacy and Field Safety of Ilunocitinib for the Control of Allergic Dermatitis in Client‐Owned Dogs: A Multicenter, Double‐Masked, Randomised, Placebo‐Controlled Clinical Trial

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 825-837, December 2025.
Background: Inhibition of the Janus kinase pathway is an established treatment for allergic dermatitis. Objective: To evaluate the efficacy and safety of ilunocitinib for control of pruritus in dogs with allergic dermatitis in a randomised, double‐masked clinical trial.
Sophie Forster   +5 more
wiley   +1 more source

Comparative efficacy of selenoureido carbonic anhydrase inhibitors and azole antifungal drugs against clinical isolates of Malassezia pachydermatis

open access: yesVeterinary Dermatology, Volume 36, Issue 3, Page 302-313, June 2025.
Background – Malassezia pachydermatis (MP) is implicated in severe dermatitis and otitis externa (OE) of companion animals and recently gained attention for its increasing resistance to azole compounds. For this reason, developing novel therapeutic strategies is of great interest. In a previous work, we used reference yeast isolates to evaluate several
Costanza Spadini   +11 more
wiley   +1 more source

陕西省87株耐药结核分枝杆菌寡核苷酸基因分型和耐药性分析 [PDF]

open access: yes, 2018
目的对陕西87例耐药结核分枝杆菌进行分型研究,了解不同基因型在陕西的流行情况及耐药相关性。方法收集陕西省结核分枝杆菌耐药菌株87株,采用Spoligotyping方法对结核分枝杆菌临床分离株进行基因分型。结果 87株耐药结核分枝杆菌中北京家族占86.21%(75/87),非北京家族占13.79%(12/87);非北京基因型中,T家族(T1、T2、T2-3、T3)占9.20%(8/87),Manu家族占1.15%(1/87),新发现基因型占3.45%(3/87)。北京家族和非北京家族的单耐药、多耐药 ...
杨健   +5 more
core  

Comparison of the in vitro antibiofilm activities of otic cleansers against canine otitis externa pathogens

open access: yesVeterinary Dermatology, Volume 36, Issue 2, Page 148-158, April 2025.
Background – Biofilm production by canine otitis externa (COE) pathogens and resistance development to multiple antimicrobials are commonly reported problems in veterinary practice. The use of adjuvants to disrupt biofilms may be a viable adjunctive therapy.
Bhumika F. Savaliya   +3 more
wiley   +1 more source

Comparison of commercial next‐generation sequencing assays to conventional culture methods for bacterial identification and antimicrobial susceptibility of samples obtained from clinical cases of canine superficial bacterial folliculitis

open access: yesVeterinary Dermatology, Volume 36, Issue 1, Page 14-23, February 2025.
Background – Bacterial identification and antimicrobial susceptibility testing is an important step in timely therapeutic decisions for canine superficial bacterial folliculitis (SBF), commonly caused by Staphylococcus pseudintermedius. Next‐generation sequencing (NGS) offers the appeal of potentially expedited results with complete detection of ...
Kimberly Smart   +4 more
wiley   +1 more source

白念珠菌基因多态性与耐药性关系 [PDF]

open access: yes, 2007
【目的】探讨耐氟康唑白念珠菌基因多态性与其耐药性是否相关。【方法】收集48株敏感白念珠菌和10株耐氟康唑白念珠菌,其中包括2株体外诱导的耐氟康唑白念珠菌。选择1个随机引物(引物1251),采用任意引物PCR方法基因分型,将电泳图谱扫描入计算机后采用Labwork4.0软件转化为数值图表,利用SPSS11.5进行聚类分析。【结果】引物1251的PCR指纹图带型稳定,多态性丰富,可以作为分型引物。聚类分析结果提示8株临床耐药菌的PCR指纹图相似系数为71.7%,而其中7株的耐药菌相似系数高达86.7 ...
刘慧   +5 more
core  

一株林麝源弗格森埃希菌的分离鉴定及耐药性

open access: yes, 2023
为探究林麝(Moschus berezovskii)的死亡原因,无菌采集死亡林麝脏器样本,通过细菌分离纯化、生化鉴定、16S rDNA基因测序、纸片扩散法和耐药基因检测方法对细菌进行分离、鉴定及分析分离菌株的耐药性。结果表明:从死亡林麝脏器样本中分离得到的菌株为弗格森埃希菌(Escherichia fergusonii),该分离菌株对头孢噻肟、头孢噻吩和青霉素耐药,对氨基糖苷类、喹诺酮类及氨基青霉素类药物敏感;携带耐药基因bla-OXA1/4/30、bla-CTX-M和bla-SHV ...
王如意   +9 more
core   +1 more source

貉源致病性肺炎克雷伯氏菌对喹诺酮类药物耐药表型及耐药基因检测

open access: yes野生动物学报, 2019
为了检测貉源致病性肺炎克雷伯氏菌对喹诺酮类药物的耐药性与耐药基因携带情况并分析其相关性,通过K-B药敏纸片和PCR方法分别检测24株貉源致病性肺炎克雷伯氏菌对喹诺酮类药物耐药性与耐药基因。结果表明:24株貉源致病性肺炎克雷伯氏菌呈现多重耐药性,对左氧氟沙星、恩诺沙星、环丙沙星、诺氟沙星耐药性为70.8%—79.2%,耐4种抗生素的菌株有16株,占分离菌株的66.7%;24株貉源致病性肺炎克雷伯氏菌的耐药基因gyrB、oqxA、parC、parE、oqxB、ompF检出率在70.8%以上 ...
张召兴 1   +1 more
doaj  

Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance

open access: yesRare Metals, Volume 43, Issue 11, Page 6006-6022, November 2024.
Graphical abstract AbstractCisplatin resistance is the main cause for the failure of cancer therapy. To solve the problem, we proposed to develop a novel human serum albumin (HSA) nanoplatform to integrate chemotherapy, photothermal therapy (PTT) and immunotherapy.
Xue‐Yu Man   +7 more
wiley   +1 more source

人胃癌耐药细胞的建立方法及意义

open access: yesZhongguo shiyan zhenduanxue, 2021
目的 建立人胃癌耐药细胞,为研究人胃癌耐药细胞的耐药机制以及为耐药肿瘤细胞的治疗提供耐药肿瘤细胞模型。方法 体外培养人胃癌细胞SGC-7901,用50μmol/L顺铂多次反复冲击,对冲击4次和6次的SGC-7901分别检测对顺铂的抑制率和多药耐药基因(MDR)及多药耐药特异基因片段的表达,并计算药物对细胞的半数抑制浓度(IC50)。结果 经4次和6次冲击后,受冲击的SGC-7901胃癌细胞对顺铂的抑制率明显高于亲本细胞,IC50为63.98μmol/L和66.34μmol/L,而亲本细胞SGC ...
刘玉侠   +6 more
doaj  

Home - About - Disclaimer - Privacy